AngioDynamics to Report Fiscal 2022 Third Quarter Financial Results on April 7, 2022

Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) will announce its third-quarter fiscal year 2022 financial results on April 7, 2022, before market opening. A conference call hosted by management will commence at 8:00 a.m. ET on the same day, allowing investors to discuss the financial outcomes. Participants can join the call via phone or access the live webcast from the AngioDynamics website. The call's recording will be available for playback shortly after its conclusion. AngioDynamics specializes in innovative, minimally invasive medical devices for various healthcare applications.

Positive

• Scheduled financial results release for Q3 fiscal year 2022 before market opens.
• Management conference call to discuss results demonstrates transparency to investors.

Negative

• None.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2022 before the market open on Thursday, April 7, 2022. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results.

To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and refer to the passcode 13727875.

This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available from 11:00 a.m. ET on Thursday, April 7, 2022, until 11:59 p.m. ET on Thursday, April 14, 2022. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13727875.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220314005796/en/

Investor Contact:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When will AngioDynamics announce its Q3 fiscal year 2022 financial results?

AngioDynamics will announce its Q3 fiscal year 2022 financial results on April 7, 2022, before the market opens.

What time is the AngioDynamics conference call for Q3 results?

The conference call will be held at 8:00 a.m. ET on April 7, 2022.

How can I participate in the AngioDynamics conference call?

To participate, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and use passcode 13727875.

Where can I access the AngioDynamics Q3 financial results webcast?

The webcast can be accessed from the 'Investors' section of the AngioDynamics website.

Will there be a recording of the AngioDynamics conference call?

Yes, a recording will be available from 11:00 a.m. ET on April 7, 2022, until April 14, 2022.